Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06BGS
|
|||
| Former ID |
DIB003817
|
|||
| Drug Name |
AIDSVAX
|
|||
| Synonyms |
AIDSVAX B/B; AIDSVAX B/E; Bivalent gp120 HIV vaccines, GSID; Bivalent gp120 HIV vaccines, Global Solutions for Infectious Diseases; Bivalent gp120 HIV vaccines, VaxGen
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 3 | [1] | |
| Company |
DiaDexus Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Envelope glycoprotein gp120 (HIV gp120) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00006327) Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand. U.S. National Institutes of Health. | |||
| REF 2 | HIV gp120 vaccine - VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine - Genentech, HIV gp120 vaccine AIDSVAX - VaxGen, HIV vaccine AIDSVAX - VaxGen. Drugs R D. 2003;4(4):249-53. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.